There were an estimated 263 million cases reported by the World Health Organization in 2023, up from about 248 million cases in 2022.. "The discovery of a new target on the sporozoite surface ...

Researchers from the National Institutes of Health (NIH) have identified a novel class of antibodies that bind to a previously untargeted region of the malaria parasite. The most potent antibody in ...

Novel anti-malaria antibodies have been identified, potentially contributing to the next generation of malaria prevention. Researchers at the National Institutes of Health (MD, USA) have identified a ...

A novel class of antibodies has been discovered that binds to a previously untargeted portion of the malaria parasite—a cryptic pGlu-CSP site on the Plasmodium falciparum (Pf) sporozoite surface.

Nearly every disease has an inflammatory component, but blood tests can't pinpoint inflammation in specific organs or tissues ...

Malaria remains a significant global health challenge, causing over 600,000 deaths annually despite existing prevention and treatment measures. Current vaccines and monoclonal antibodies (mAbs) ...

falciparum malaria vaccine candidates that are presently ... to safely optimize antigen presentation and induce higher antibody and T-cell responses. Following these unprecedented results from ...

Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby providing protection. But Scripps Research scientists have now discovered that for some HIV ...

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

Scientists have discovered a new type of anti-malarial antibody that doesn't interfere with current vaccines, at least in mouse models. Could they help eliminate malaria in the future? https://p ...